Of 34 Cd19 Wwox KO mice, 8 (23.4%) developed (B220+) B cell lymphomas and 8 other mice developed plasmacytomas (B220+,CD138+) predominantly affecting mesenteric and retroperitoneal lymph nodes. This evidence concerns the gene WWOX and B-cell non-Hodgkin lymphoma.